Integrative genomics reveals pathogenic mediator of valproate-induced neurodevelopmental disability

Prenatal exposure to the anti-seizure medication sodium valproate (VPA) is associated with an increased risk of adverse postnatal neurodevelopmental outcomes, including lowered intellectual ability, autism spectrum disorder and attention-deficit hyperactivity disorder. In this study, we aimed to cla...

Descripción completa

Detalles Bibliográficos
Autores principales: Feleke, Rahel, Jazayeri, Dana, Abouzeid, Maya, Powell, Kim L, Srivastava, Prashant K, O’Brien, Terence J, Jones, Nigel C, Johnson, Michael R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679160/
https://www.ncbi.nlm.nih.gov/pubmed/36071595
http://dx.doi.org/10.1093/brain/awac296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679160/
https://www.ncbi.nlm.nih.gov/pubmed/36071595
http://dx.doi.org/10.1093/brain/awac296

Ejemplares similares